NPS RADAR August 2009NPS RADAR August 2009

NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.

Find out more about NPS RADAR.



Title Why read this
NPS RADAR August 2009 Professional publication - NPS RADAR - Complete issue NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Teriparatide (Forteo) for severe osteoporosis Professional publication - NPS RADAR - Review Teriparatide is subsidised on the Pharmaceutical Benefits Scheme for severe established osteoporosis in people at very high risk of fracture who develop one or more new symptomatic fractures despite at least 12 months of continuous antiresorptive therapy.
Rivaroxaban (Xarelto) for preventing venous thromboembolism after hip or knee replacement surgery Professional publication - NPS RADAR - Review Rivaroxaban is an oral factor Xa–inhibitor anticoagulant. It is approved for short-term use to prevent deep vein thrombosis and pulmonary embolism after elective total hip or total knee replacement surgery.
Praziquantel (Biltricide) tablets PBS listed for schistosomiasis Professional publication - NPS RADAR - Brief item Praziquantel tablets (600mg) have been listed as an authority-required (streamlined) benefit on the PBS as of 1 August 2009.
Oxybutynin patch (Oxytrol) PBS listed as an alternative for overactive bladder Professional publication - NPS RADAR - Brief item Oxybutynin patches (Oxytrol) have been listed on the PBS as a restricted benefit for people who have detrusor overactivity and cannot tolerate or swallow oral oxybutynin.
Aboriginal and Torres Strait Islander peoples PBS listings Professional publication - NPS RADAR - Brief item Since August 2006 a number of medicines have been listed on the Pharmaceutical Benefits Scheme (PBS) specifically for people who identify as Aboriginal or Torres Strait Islander. This article lists medicines currently subsidised on the PBS for treating common conditions in Aboriginal and Torres Strait Islander peoples.
Sitagliptin with metformin (Janumet) fixed-dose combination tablets PBS listed for type 2 diabetes mellitus Professional publication - NPS RADAR - Brief item Sitagliptin with metformin tablets (Janumet) in fixed-dose combinations of 50/500 mg, 50/850 mg and 50/1000 mg are available on the PBS as of 1 August 2009.
Risedronate (Actonel Once-a-month) and summary of anti-resorptive drug listings Professional publication - NPS RADAR - Brief item Risedronate once-monthly tablets are now PBS-listed for the treatment of osteoporosis. A summary of anti-resorptive drug listings for osteoporosis is provided.
Clopidogrel (Iscover, Plavix) PBS listing extended to cardiac stent insertion Professional publication - NPS RADAR - Brief item Clopidogrel, in combination with aspirin, can be prescribed on the PBS following coronary artery stent insertion.

Complete list of all NPS RADAR content.

Find out more about NPS RADAR.

Keep track of what's new by RSS FeedKeep track of what's new by RSS Feed
RSS FeedRSS feed

Date published: 2009-08-01 00:00:00

Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.

References to brands should not be taken as an endorsement by NPS.